LIN vs MRVI · P/E 34, rev $18.07B vs rev $117.3M
Linde plc Ordinary Shares (LIN) versus Maravai Lifesciences Holdings Inc (MRVI) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.
Latest reported LIN revenue for 2026-06-30 was $18.07B. Net income was $3.79B. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported MRVI revenue for 2026-06-30 was $117.3M. Net income was -$16.1M. Revenue was up 78.1% from 2026-03-31 to 2026-06-30. MRVI currently screens at market cap $1.93B.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. MRVI currently screens at market cap $1.93B.
Not investment advice. Open the LIN and MRVI stock pages for the full models.
Not investment advice.